Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
13%(1 trials)

Phase Distribution

Ph phase_1
7
64%
Ph phase_2
4
36%

Phase Distribution

7

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
7(63.6%)
Phase 2Efficacy & side effects
4(36.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 17 (63.6%)
Phase 24 (36.4%)

Trials by Status

completed873%
unknown327%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_2

Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury

NCT01851083
completedphase_2

Outcomes of Stem Cells for Cerebral Palsy

NCT02574923
completedphase_1

Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells

NCT01575470
completedphase_2

Autologous Bone Marrow Stem Cell Therapy for Autism

NCT02627131
completedphase_2

Outcomes of Stem Cells for Cerebral Palsy

NCT02569775
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT01851083Phase 2

Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury

Completed
NCT02574923Phase 2

Outcomes of Stem Cells for Cerebral Palsy

Completed
NCT01575470Phase 1

Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells

Completed
NCT02627131Phase 2

Autologous Bone Marrow Stem Cell Therapy for Autism

Completed
NCT02569775Phase 2

Outcomes of Stem Cells for Cerebral Palsy

Completed
NCT00859014Phase 1

Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients

Completed
NCT00872326Phase 1

Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia

Completed
NCT01209611Phase 1

Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration

Unknown
NCT01937416Phase 1

Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia

Unknown
NCT01536106Phase 1

Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.

Unknown
NCT01028794Phase 1

Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients

Completed

All 11 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11